CASIA OpenIR
(本次检索基于用户作品认领结果)

浏览/检索结果: 共5条,第1-5条 帮助

限定条件        
已选(0)清除 条数/页:   排序方式:
Sensitive and quantitative in vivo analysis of PD‑L1 using magnetic particle imaging and imaging‑guided immunotherapy 期刊论文
European Journal of Nuclear Medicine and Molecular Imaging, 2022, 卷号: 50, 页码: 1291-1305
作者:  Zhengyao Peng;  Chang Lu;  Guangyuan Shi;  Lin Yin;  Xiaolong Liang;  Guosheng Song;  Jie Tian;  Yang Du
Adobe PDF(4924Kb)  |  收藏  |  浏览/下载:58/22  |  提交时间:2024/05/28
DERnet: a deep neural network for end-to-end reconstruction in magnetic particle imaging 期刊论文
PHYSICS IN MEDICINE AND BIOLOGY, 2024, 卷号: 69, 期号: 1, 页码: 15
作者:  Peng, Zhengyao;  Yin, Lin;  Sun, Zewen;  Liang, Qian;  Ma, Xiaopeng;  An, Yu;  Tian, Jie;  Du, Yang
Adobe PDF(1035Kb)  |  收藏  |  浏览/下载:122/9  |  提交时间:2024/02/22
magnetic particle imaging  end-to-end reconstruction  deep learning  image reconstruction  
Advances in Molecular Imaging of Immunotherapeutic Targets in Breast Cancer: Current and Future Prospect 期刊论文
European Radiology, 2018, 期号: NA, 页码: NA
作者:  Du Yang;  Jin Yinhua;  Sun Wei;  Fan Junjie;  Zheng Jianjun;  Tian Jie
浏览  |  Adobe PDF(6002Kb)  |  收藏  |  浏览/下载:393/85  |  提交时间:2019/02/18
Cancer, Immunotherapy, Molecular Imaging, Immune Checkpoint Target  
Liposomal Nanohybrid Cerasomes Targeted to PD-L1 Enable Dual-Modality Imaging and Improve Antitumor Treatments 期刊论文
Cancer Letters, 2018, 期号: 414, 页码: 230-238
作者:  Du Yang;  Xiaolong Liang;  Yuan Li;  Ting Sun;  Huadan Xue;  Zhengyu Jin;  Jie Tian
浏览  |  Adobe PDF(2955Kb)  |  收藏  |  浏览/下载:252/90  |  提交时间:2019/02/18
Programmed Cell Death Ligand-1, Near Infrared FLuorescence, Magnetic Resonance Imaging, Paclitaxel, Chemotherapy, Immunotherapy  
Liposomal nanohybrid cerasomes targeted to PD-L1 enable dual-modality imaging and improve antitumor treatments 期刊论文
CANCER LETTERS, 2018, 卷号: 414, 期号: 414, 页码: 230-238
作者:  Du, Yang;  Liang, Xiaolong;  Li, Yuan;  Sun, Ting;  Xue, Huadan;  Jin, Zhengyu;  Tian, Jie
Adobe PDF(3002Kb)  |  收藏  |  浏览/下载:580/240  |  提交时间:2018/01/03
Programmed Cell Death Ligand-1  Near Infrared Fluorescence  Magnetic Resonance Imaging  Paclitaxel  Chemotherapy  Immunotherapy